REDOX PHARMACEUTICAL

Redox Pharmaceutical Corporation develops a family of metallo-organic compounds for antiviral, antibacterial, and anti-inflammatory applications. The company offers Doxovir, a formulation for dermal clinical, ophthalmic herpes virus and adenovirus infections, and anti-inflammatory applications; and Doxovir-M for sexually transmitted diseases. It offers its products for ocular applications, such as adenovirus-derived, keratoconjunctivitis, and herpetic keratitis; dermal applications, including facial herpes; non-steroidal anti-inflammatory applications; genital applications, which include HIV, human papillomavirus, and genital herpes; and medical applications. The company was founded in 1980 and is based in New York, New York.